Recent Financial News:More >>
10 November 2009
Elan to Present at Lazard Capital Markets 6th Annual Healthcare Conference| DUBLIN, Ireland, Nov 10, 2009 (BUSINESS WIRE) -- Elan Corporation, plc (NYSE: ELN) today announced that it will present
at the Lazard Capital Markets 6th Annual Healthcare
Conference, on Tuesday, November 17, 2009 at; 9:55 a.m. Eastern Time and
2:55 p.m. GMT.
Interested parties may access a live audio web cast of the presentation
by visiting the Investor Relations section of the Elan website at www.elan.com,
then clicking on the event icon. Following the ... |
| 29 October 2009
Elan Corporation Plc Announces Expiration of Tender Offer for 7¾% Senior Fixed Rate Notes Due 2011| DUBLIN--(BUSINESS WIRE)--Oct. 29, 2009--
Elan Corporation, plc (NYSE: ELN) ("Elan") today announced the
expiration and final results of the tender offer for the 7¾% Senior
Fixed Rate Notes due 2011 (CUSIP No. 284138AC8) (the “Notes”) issued by
its wholly-owned subsidiaries, Elan Finance public limited company and
Elan Finance Corp. (the “Co-Issuers”). The tender offer expired on
October 28, 2009, at 11:59 p.m., New York City time (the "Expiration
... |
| 27 October 2009
Subset Data from Two Randomized Phase 3 Trials Show TYSABRI Significantly Reduces Rates of Hospitalization in Patients with Moderate-to-Severe Crohn's Disease| DUBLIN & SAN DIEGO--(BUSINESS WIRE)--Oct. 27, 2009--
Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) today
announced data showing that treatment with TYSABRI®
(natalizumab) significantly reduced the rate of hospitalization compared
with placebo in patients with moderate–to–severe Crohn’s disease during
both induction and maintenance treatment. These results were obtained
from retrospective subset analyses of three registrational Phas... |
| 21 October 2009
Elan Reports Third Quarter 2009 Financial Results| DUBLIN--(BUSINESS WIRE)--Oct. 21, 2009--
Elan Corporation, plc today reported its third quarter 2009 financial
results.
Elan CEO Kelly Martin said, “The third quarter of 2009 proved to be a
time of significant transformation for Elan. Completion of the Johnson &
Johnson transaction and the subsequent refinancing of our balance sheet
provide strategic flexibility and financial stability for the company.”
He added, R... |
|
 |
Upcoming Events:More >>
| There are currently no events scheduled. |
Receive E-mail Alerts | | Sign up to receive e-mail alerts whenever Elan Corporation, PLC posts new information to the site. Just enter your e-mail address and click Submit. |
|
RSS Feeds | 
E-mail Alerts | 
Contact IR